Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.
Zhang XF, Weng DS, Pan K, Zhou ZQ, Pan QZ, Zhao JJ, Tang Y, Jiang SS, Chen CL, Li YQ, Zhang HX, Chang AE, Wicha MS, Zeng YX, Li Q, Xia JC.
Zhang XF, et al. Among authors: chang ae.
Mol Carcinog. 2017 Nov;56(11):2499-2511. doi: 10.1002/mc.22697. Epub 2017 Sep 14.
Mol Carcinog. 2017.
PMID: 28621442
Free article.